v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net income     $ 601,501 $ 554,187  
Adjustments to reconcile net income to cash provided by (used in) operating activities:          
Change in future policy benefits and other policy liabilities     90,576 33,210  
Deferral of policy acquisition costs     (377,387) (407,712)  
Amortization of deferred policy acquisition costs $ 86,592 $ 81,498 255,979 240,091  
Change in income taxes     (56,221) (48,382)  
Investment (gains) losses 169 (652) (1,917) 1,457  
Accretion and amortization of investments     (3,026) (2,510)  
Depreciation and amortization     12,248 14,337  
Change in reinsurance recoverables     164,474 203,525  
Change in agent balances, due premiums and other receivables     (27,226) (18,479)  
Trading securities sold, matured, called or (acquired), net     (19,672) (9,610)  
Share-based compensation     17,923 19,802  
Change in other operating assets and liabilities, net     (15,254) (16,982)  
Net cash provided by (used in) operating activities     641,998 562,934  
Available-for-sale investments sold, matured or called:          
Fixed-maturity securities — sold     13,778 18,328  
Fixed-maturity securities — matured or called     505,951 349,949  
Short-term investments - matured or called     5,000 0  
Equity securities — sold     0 26  
Equity securities — matured or called     0 1,829  
Available-for-sale investments acquired:          
Fixed-maturity securities     (710,609) (468,324)  
Short-term investments     (4,950) 0  
Equity securities — acquired     (189) (169)  
Purchases of property and equipment and other investing activities, net     (39,076) (17,450)  
Cash collateral received (returned) on loaned securities, net     (4,691) 18,501  
Sales (purchases) of short-term investments using securities lending collateral, net     4,691 (18,501)  
Cash received from redemption of deposit asset     131,418 0  
Net cash provided by (used in) investing activities     (98,677) (115,811)  
Cash flows from financing activities:          
Dividends paid     (112,659) (102,764)  
Common stock repurchased     (392,314) (376,062)  
Excise tax paid on common stock repurchased     (4,208) (3,910)  
Tax withholdings on share-based compensation     (6,079) (8,697)  
Finance leases     (176) (205)  
Net cash provided by (used in) financing activities     (515,436) (491,638)  
Effect of foreign exchange rate changes on cash     (1,389) 1,549  
Change in cash and cash equivalents     26,496 (42,966)  
Cash and cash equivalents, beginning of period     756,227 687,821 $ 687,821
Cash and cash equivalents, end of period $ 782,723 $ 644,855 $ 782,723 $ 644,855 $ 756,227